IntelliPharmaCeutics International (TSXV:IPCI) Net Margin % : -2,737.63% (As of Aug. 2023)

View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. IntelliPharmaCeutics International's Net Income for the three months ended in Aug. 2023 was C$-2.55 Mil. IntelliPharmaCeutics International's Revenue for the three months ended in Aug. 2023 was C$0.09 Mil. Therefore, IntelliPharmaCeutics International's net margin for the quarter that ended in Aug. 2023 was -2,737.63%.

The historical rank and industry rank for IntelliPharmaCeutics International's Net Margin % or its related term are showing as below:

TSXV:IPCI' s Net Margin % Range Over the Past 10 Years
Min: -4373.03 Med: -241.84 Max: -43.97
Current: -350.12

TSXV:IPCI's Net Margin % is ranked worse than
59.92% of 1028 companies
in the Biotechnology industry
Industry Median: -154.79 vs TSXV:IPCI: -350.12

IntelliPharmaCeutics International Net Margin % Historical Data

The historical data trend for IntelliPharmaCeutics International's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Net Margin % Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Net Margin %

Get a 7-Day Free Trial

-802.52

-232.25

-241.84

-4,373.03

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Net Margin %	Get a 7-Day Free Trial															-1,528.00	-2,942.50	-109.11	-11.25	-2,737.63

Competitive Comparison of IntelliPharmaCeutics International's Net Margin %

For the Biotechnology subindustry, IntelliPharmaCeutics International's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Net Margin % distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Net Margin % falls into.

IntelliPharmaCeutics International Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

IntelliPharmaCeutics International's Net Margin for the fiscal year that ended in Nov. 2022 is calculated as

Net Margin	=	Net Income (A: Nov. 2022 )	/	Revenue (A: Nov. 2022 )
	=	-3.892	/	0.089
	=	-4,373.03 %

IntelliPharmaCeutics International's Net Margin for the quarter that ended in Aug. 2023 is calculated as

Net Margin	=	Net Income (Q: Aug. 2023 )	/	Revenue (Q: Aug. 2023 )
	=	-2.546	/	0.093
	=	-2,737.63 %

IntelliPharmaCeutics International (TSXV:IPCI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

IntelliPharmaCeutics International Net Margin % Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

IPCIF:USA I4AA:Germany

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines